Pablo G. Legorreta - CEO, Chairman of the Board, Director, 10%+ Owner at Royalty Pharma plc

Insider Transactions and Holdings

Entity Type
Individual
Role
CEO, Chairman of the Board, Director, 10%+ Owner
Stock Symbol
RPRX on Nasdaq
Industry
Pharmaceutical Preparations
All Insider Reports
All Insider Reports

There are no Buy or Sell transactions made by Pablo G. Legorreta since 7/7/2023

Holdings reported by Pablo G. Legorreta for Royalty Pharma plc

Class Num Shares Value Price $ Report Date Ownership Underlying Class Underlying Amount
Class A ordinary shares 292,190 $8.05 M $27.55 Dec 30, 2022 By Tata MC 35 Ltd.
Class A ordinary shares 63,795 $1.76 M $27.55 Nov 16, 2023 Direct
LP interests in RPI US Partners 2019, LP 2,862,363 Dec 31, 2022 By Legorreta Investments II LLC Class A Ordinary Shares 28,623,630
LP interests in RPI US Partners 2019, LP 2,700,000 Aug 12, 2022 By Legorreta Investments LLC Class A Ordinary Shares 28,506,400
ICAI Interests 1,007,488 May 12, 2023 By Legorreta Investments LLC Limited Partnership interests in RPI US Partners 2019, LP 1,007,488
ICAI Interests 692,701 May 12, 2023 Direct Limited Partnership interests in RPI US Partners 2019, LP
LP interests in RPI US Partners 2019, LP 147,014 Dec 31, 2022 By Spouse Class A Ordinary Shares 1,470,140
ICAI Interests 0 May 12, 2023 By Spouse Limited Partnership interests in RPI US Partners 2019, LP

Transactions reported by Pablo G. Legorreta for Royalty Pharma plc

Sym Class Transaction % Value $ Price $ Shares Shares After Date Ownership